Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
難治性ホジキンリンパ腫におけるニボルマブでのPD-1遮断
Document Type and Number:
Japanese Patent JP7175198
Kind Code:
B2
Abstract:
This disclosure provides to methods for treating Hodgkin lymphoma in a subject comprising nivolumab, a PD-1-blocking antibody, that inhibits tumor immune evasion in patients with relapsed or refractory Hodgkin's lymphoma.

Inventors:
Benedetto Farsachi
Application Number:
JP2018563008A
Publication Date:
November 18, 2022
Filing Date:
June 01, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BRISTOL-MYERS SQUIBB COMPANY
International Classes:
C07K16/28; A61K31/475; A61K31/655; A61K31/704; A61K39/395; A61P35/02
Domestic Patent References:
JP2015518826A
Other References:
Eur. J. Heamatol., Published online 2016.05.30, Vol.97, pp.219-227
Curr. Opin. Pharmacol., 2015, Vol.23, pp.32-38
N. Engl.J. Med., 2015, Vol.371, No.4, pp.311-319
J. Clin. Oncol., Published online 2016.05.20, Vol.34, No.15_suppl, 7535
Blood, 2014, Vol.121, No.21, 290
Lancet Oncol., 2013, Vol.14, pp.1348-1356
日薬理誌, 2015, Vol.146, pp.106-114
Attorney, Agent or Firm:
Yamato Kento
Norifumi Tomita
Fumio Inai
Manami Sasakura